Keyphrases
Epithelial Ovarian Cancer
100%
Carboplatin
100%
Phase II Study
100%
Complete Remission
75%
Overall Survival
75%
Platinum-based
50%
Disease-free Survival
50%
5-year Survival
50%
Recurring
25%
Survival Value
25%
Confidence Interval
25%
Anemia
25%
First-line Therapy
25%
Combination Chemotherapy
25%
Thrombocytopenia
25%
Computerized Tomography
25%
Complete Recovery
25%
Platinum-based Chemotherapy
25%
Previously Treated
25%
Stage III-IV
25%
Recurrent Disease
25%
Time to Progression
25%
Cancer Stage
25%
2-cycles
25%
Maintenance Treatment
25%
Advanced Ovarian Cancer
25%
Serum CA125
25%
Pelvic Examination
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Carcinoma
100%
Carboplatin
100%
Remission
75%
Overall Survival
75%
Chemotherapy
50%
Disease Free Survival
50%
Recurrent Disease
25%
Anemia
25%
Cancer Staging
25%
Survival Rate
25%
Thrombocytopenia
25%
Erethism
25%
Diseases
25%
Medicine and Dentistry
Krukenberg Tumor
100%
Carboplatin
100%
Overall Survival
75%
Disease Free Survival
50%
Survival Rate
25%
Recurrent Disease
25%
Computer Assisted Tomography
25%
Anemia
25%
Combination Chemotherapy
25%
Cancer Staging
25%
Thrombocytopenia
25%
Hypersensitivity
25%
Maintenance Therapy
25%
CA-125
25%
Pelvic Examination
25%
Diseases
25%